Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$381.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.19 | 1.02%
Avg Daily Range (30 D):	$2.44 | 1.19%
Avg Daily Range (90 D):	$2.52 | 1.17%

Institutional Daily Volume
Avg Daily Volume:	6.11M
Avg Daily Volume (30 D):	4.62M
Avg Daily Volume (90 D):	4.87M

Trade Size
Avg Trade Size (Sh.):	102
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	64,775
Avg Institutional Trade:	$10.76M
Avg Institutional Trade (30 D):	$26.56M
Avg Institutional Trade (90 D):	$27.04M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$93.25M
Avg Closing Trade (30 D):	$220M
Avg Closing Trade (90 D):	$290.72M
Avg Closing Volume:	789.41K

News

May 23, 2026 @ 1:15 AM The Smartest Growth Stocks to Invest $10,000 in As... Source: Reuben Gregg Brewer

May 20, 2026 @ 11:00 AM Ichnos Glenmark Innovation (IGI) Announces New Dev... Source: Na

May 19, 2026 @ 5:00 PM Pulmonary Arterial Hypertension Clinical Trial Pip... Source: Delveinsight

May 19, 2026 @ 1:30 PM 2 Stocks That Are Much Cheaper Than They Look Source: David Jagielski, Cpa

May 19, 2026 @ 10:30 AM 2 High-Yield Healthcare Stocks to Buy Before They ... Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$2.03	$.39	$1.02
Diluted EPS	$2.03	$.39	$1.02
Revenue	$62.82B	$15B	$16.62B
Gross Profit	$44.4B	$10.78B	$12.07B
Net Income / Loss	$3.64B	$697M	$1.82B
Operating Income / Loss	$15.33B	$3.99B	$4.54B
Cost of Revenue	$18.42B	$4.22B	$4.55B
Net Cash Flow	$4.22B	$4.16B	$-400M
PE Ratio